D-0110-2017 Class III Terminated
FDA drug recall D-0110-2017 was initiated by Teva Pharmaceuticals USA on Sep 22, 2016 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing. The recall status is terminated (terminated May 5, 2017). Affected quantity: 5,556 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 26, 2016
- Initiation Date
- Sep 22, 2016
- Termination Date
- May 5, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 5,556 bottles
Product description
PARICALCITOL Capsules, 2 mcg, 30-count bottles, Rx only, Manufactured By: Pharmaceutics International, Inc., Hunt Vallet, MD 21031; Manufactured For: Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 0093-7657-56.
Reason for recall
Failed Impurities/Degradation Specifications: out of specification test results for impurities during stability testing.
Distribution pattern
Nationwide and Puerto Rico
Code information
Lot #: 13016.011A, Exp 03/17
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0110-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026